These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7727540)

  • 41. Breakdown of gliadin peptides by intestinal brush borders from coeliac patients.
    Bruce G; Woodley JF; Swan CH
    Gut; 1984 Sep; 25(9):919-24. PubMed ID: 6381246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolation and enzymatic fragmentation of the coeliac-active gliadin peptide CT-1.
    Wieser H; Belitz HD
    Z Lebensm Unters Forsch; 1992 Jul; 195(1):22-6. PubMed ID: 1502855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge.
    Kontakou M; Przemioslo RT; Sturgess RP; Limb GA; Ellis HJ; Day P; Ciclitira PJ
    Gut; 1995 Jul; 37(1):52-7. PubMed ID: 7672681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of natural and synthetic peptides derived from gliadin with different cell lines.
    Farré MA; Tlaskalová H; Nguyen HH; Kocna P; Tucková L; Krchnák V; Vetvicka V; Baudisová M; Pospisil M; Fric P
    Adv Exp Med Biol; 1995; 371B():1371-3. PubMed ID: 7502820
    [No Abstract]   [Full Text] [Related]  

  • 45. Coeliac disease: characterisation of monoclonal antibodies raised against a synthetic peptide corresponding to amino acid residues 206-217 of A-gliadin.
    Ellis HJ; Doyle AP; Sturgess RP; Ciclitira PJ
    Gut; 1992 Nov; 33(11):1504-7. PubMed ID: 1280610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo gluten ingestion in coeliac disease.
    Ciclitira PJ; Ellis HJ
    Dig Dis; 1998; 16(6):337-40. PubMed ID: 10207218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: implications for coeliac disease.
    Rivabene R; Mancini E; De Vincenzi M
    Biochim Biophys Acta; 1999 Jan; 1453(1):152-60. PubMed ID: 9989255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa.
    Cornell HJ; Auricchio RS; De Ritis G; De Vincenzi M; Maiuri L; Raia V; Silano V
    Pediatr Res; 1988 Aug; 24(2):233-7. PubMed ID: 3186334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxicity of wheat gliadin fractions in coeliac disease.
    Townley RR; Cornell HJ; Bhathal PS; Mitchell JD
    Lancet; 1973 Jun; 1(7816):1363-4. PubMed ID: 4122746
    [No Abstract]   [Full Text] [Related]  

  • 50. In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac disease.
    Mantzaris G; Jewell DP
    Scand J Gastroenterol; 1991 Apr; 26(4):392-8. PubMed ID: 1827928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: an in vivo/in vitro pilot study.
    Ciacci C; Maiuri L; Russo I; Tortora R; Bucci C; Cappello C; Santonicola A; Luciani A; Passananti V; Iovino P
    Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):1170-6. PubMed ID: 19473192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioactive antinutritional peptides derived from cereal prolamins: a review.
    Silano M; De Vincenzi M
    Nahrung; 1999 Jun; 43(3):175-84. PubMed ID: 10399351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Digestion of gliadin peptides by intestinal mucosa from control or coeliac children.
    Carchon H; Serrus M; Eggermont E
    Digestion; 1979; 19(1):1-5. PubMed ID: 378739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-specific cytotoxicity of wheat gliadin components towards cultured human cells.
    Hudson DA; Cornell HJ; Purdham DR; Rolles CJ
    Lancet; 1976 Feb; 1(7955):339-41. PubMed ID: 54743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-alpha-gliadin antibodies (AGA) in the serum of coeliac children and controls recognize an identical collection of linear epitopes of alpha-gliadin.
    ten Dam M; Van De Wal Y; Mearin ML; Kooy Y; Peña S; Drijfhout JW; Koning F; Van Tol M
    Clin Exp Immunol; 1998 Nov; 114(2):189-95. PubMed ID: 9822275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of gliadin on fetal chick intestine in tissue culture.
    Mothes T; Mühle W; Müller F; Hekkens WT
    Biol Neonate; 1985; 48(1):59-64. PubMed ID: 3899195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Possible role for a human adenovirus in the pathogenesis of celiac disease.
    Kagnoff MF; Austin RK; Hubert JJ; Bernardin JE; Kasarda DD
    J Exp Med; 1984 Nov; 160(5):1544-57. PubMed ID: 6491604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease.
    Matysiak-Budnik T; Candalh C; Cellier C; Dugave C; Namane A; Vidal-Martinez T; Cerf-Bensussan N; Heyman M
    Gastroenterology; 2005 Sep; 129(3):786-96. PubMed ID: 16143118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epithelial transport of immunogenic and toxic gliadin peptides in vitro.
    Zimmermann C; Rudloff S; Lochnit G; Arampatzi S; Maison W; Zimmer KP
    PLoS One; 2014; 9(11):e113932. PubMed ID: 25415429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.
    Ankelo M; Kleimola V; Simell S; Simell O; Knip M; Jokisalo E; Tarkia M; Westerlund A; He Q; Viander M; Ilonen J; Hinkkanen AE
    Clin Exp Immunol; 2007 Nov; 150(2):285-93. PubMed ID: 17803713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.